| Hans-Günter Meyer-Thompson | Hepatitiden
New Drug Classes Seek to Further Improve Already Favorable Outcomes in Hepatitis C
The Liver Meeting 2016: American Association for the Study of Liver Diseases (AASLD). (medscape.com, 24.01.2017)